Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7
- 1 January 2002
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 9 (2) , 85-94
- https://doi.org/10.1038/sj.gt.3301627
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 48 references indexed in Scilit:
- Activation of peritoneal cells upon in vivo transfection with a recombinant alphavirus expressing GM-CSFGene Therapy, 2001
- Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7Gene Therapy, 2000
- Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A geneGene Therapy, 1999
- Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative TumorsThe Journal of Experimental Medicine, 1998
- Semliki Forest virus-based DNA expression vector: transient protein production followed by cell deathGene Therapy, 1998
- Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancerVaccine, 1996
- A new foreign policy: MHC class I molecules monitor the outside worldImmunology Today, 1996
- Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16‐induced tumorsEuropean Journal of Immunology, 1995
- High Frequency of Latent and Clinical Human Papillomavirus Cervical Infections in Immunocompromised Human Immunodeficiency Virus-Infected WomenObstetrics & Gynecology, 1992
- Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.The Journal of Experimental Medicine, 1988